Phase
Condition
Bladder Cancer
Urothelial Cancer
Treatment
Metformin Hydrochloride 500 MG
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Non-diabetic adults of age between 18 to 65.
Chemotherapy naïve patients diagnosed with bladder cancer.
Patients with stable renal function: eGFR is above 60 ml/min/1.73 m2
Exclusion
Exclusion Criteria:
Patients with history of lactic acidosis.
Patients taking any nephrotoxic medication other than cisplatin (e.g., frusemide,NSAIDs, aminoglycoside or vancomycin).
Unstable renal function (defined as an increase in serum creatinine of 0.3 mg/dL orgreater suddenly in 48 hours according to the acute kidney injury network (AKIN)classification
Patients with heart failure, acute myocardial infarction or cardiogenic collapse (shock).
Severe infection and sepsis.
Any infection requiring hospitalization.
Any infection leading to a need for oxygen, intubation, vasopressors or fluidsto support blood pressure.
Alcohol intake.
Respiratory failure.
Severe hepatic impairment (Child-Pugh class C).
Patients with metastasis.
Study Design
Connect with a study center
faculty of pharmacy Cairo university
Cairo,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.